ClinicalTrials.govpublic full text
Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.
type 2 diabetes mellitus, diabetic kidney disease, diabetic nephropathy, renal hypoxia, renoprotection, sglt2 inhibitor, ertugliflozin, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801574
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.